We are live on ! Find out more
BC

Bruce & Co Portfolio holdings

AUM $350M
1-Year Est. Return 33.5%
This Fund
S&P 500
This Quarter Est. Return
+11.07%
1 Year Est. Return
+33.5%
3 Year Est. Return
+65.72%
5 Year Est. Return
+73.85%
10 Year Est. Return
+249.08%
AUM
$500M
AUM Growth
+$29.5M
Cap. Flow
-$36.4M
Cap. Flow %
-7.28%
Top 10 Hldgs %
73.02%
Holding
31
New
Increased
1
Reduced
6
Closed

Top Buys

Rank Stock Value
1
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
+$474K

Sector Composition

Rank Sector Weight
1 Healthcare 38.91%
2 Utilities 28.57%
3 Industrials 12.91%
4 Financials 7.09%
5 Technology 5.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UHAL icon
1
U-Haul Holding Co
UHAL
$13.9B
$54.7M 10.94%
753,550
-44,300
-6% -$3.19M
NEE icon
2
NextEra Energy
NEE
$185B
$45.8M 9.15%
490,400
-11,000
-2% -$951K
ABBV icon
3
AbbVie
ABBV
$450B
$41.1M 8.22%
303,500
BHC icon
4
Bausch Health
BHC
$1.8B
$38.1M 7.62%
1,381,000
ALL icon
5
Allstate
ALL
$64.3B
$35.2M 7.04%
299,300
-500
-0.2% -$59.1K
PFE icon
6
Pfizer
PFE
$143B
$32.1M 6.42%
543,700
-1,000
-0.2% -$49.5K
CMS icon
7
CMS Energy
CMS
$22.8B
$30.5M 6.09%
468,500
DUK icon
8
Duke Energy
DUK
$97.5B
$30M 6%
286,200
AAPL icon
9
Apple
AAPL
$4.9T
$29.7M 5.94%
167,400
-75,300
-31% -$11.9M
XEL icon
10
Xcel Energy
XEL
$49.2B
$27.9M 5.58%
412,500
ABT icon
11
Abbott
ABT
$175B
$25M 5%
177,600
MRK icon
12
Merck
MRK
$315B
$24.8M 4.96%
323,700
SUPN icon
13
Supernus Pharmaceuticals
SUPN
$2.79B
$11.7M 2.34%
402,105
GE icon
14
GE Aerospace
GE
$364B
$9.86M 1.97%
167,532
AVA icon
15
Avista
AVA
$3.45B
$8.71M 1.74%
205,000
PRTK
16
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$6.48M 1.3%
1,443,312
+100,000
+7% +$474K
SIRI icon
17
SiriusXM
SIRI
$10.3B
$5.45M 1.09%
85,784
NEM icon
18
Newmont
NEM
$95.8B
$4.03M 0.81%
65,000
AMYT
19
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$3.4M 0.68%
315,182
-92,258
-23% -$996K
FOCL
20
EDAP TMS S.A.
FOCL
$204M
$3.39M 0.68%
565,652
FATE icon
21
Fate Therapeutics
FATE
$324M
$3.33M 0.67%
57,000
ASH icon
22
Ashland
ASH
$3.14B
$2.69M 0.54%
25,000
MNKD icon
23
MannKind Corp
MNKD
$1.25B
$1.73M 0.35%
395,073
IGMS
24
DELISTED
IGM Biosciences
IGMS
$1.61M 0.32%
55,000
OGN icon
25
Organon & Co
OGN
$3.55B
$985K 0.2%
32,370

Similar funds

Bruce & Co's Q4 2021 Portfolio in Review

As of Q4 2021, Bruce & Co held 31 positions worth $500M, up 6.3% from $471M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Bruce & Co withdrew a net $36.4M in Q4 2021, reducing 6 holdings. Its largest reduction was Apple, cutting an estimated $11.9M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 37% a quarter earlier, followed by Utilities and Industrials.

Against the trend, Bruce & Co added an estimated $474K to Paratek Pharmaceuticals, Inc..

  • Bruce & Co added most to Paratek Pharmaceuticals, Inc. in Q4 2021, an estimated $474K increase.
  • Bruce & Co's biggest Q4 2021 reduction was Apple, cutting an estimated $11.9M.
  • Bruce & Co's ten largest holdings make up 73% of its $500M portfolio in Q4 2021.
  • Bruce & Co opened 0 new positions and closed 0 in Q4 2021.
  • Bruce & Co's portfolio value rose 6.3% quarter-over-quarter to $500M.

Based on Bruce & Co's 13F filing for Q4 2021, filed 16 Feb 2022.